To the full analysis
Fulgent Genetics stock: growth
FLGTFulgent Genetics reported $322.67M in revenue for fiscal 2025, up 13.8% on the prior year, down 5.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
65.3%
per year from 2014 to 2025, per share 57.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2014 | |
|---|---|---|---|
| Revenue | −5.2% | 42.2% | 65.3% |
| Revenue per share | −10.8% | 30.2% | 57.2% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2014 | $1.28M | −$4.28M | −$5.13M |
| 2015 | $9.58M | −$8.31M | −$3.07M |
| 2016 | $18.28M | −$5.35M | $617K |
| 2017 | $18.73M | −$2.51M | −$4.03M |
| 2018 | $21.36M | −$5.61M | −$3.51M |
| 2019 | $32.53M | −$411K | $4.34M |
| 2020 | $421.71M | $214.31M | $104.12M |
| 2021 | $992.58M | $507.36M | $514.73M |
| 2022 | $618.97M | $143.4M | $234.75M |
| 2023 | $289.21M | −$167.83M | $4.8M |
| 2024 | $283.47M | −$42.71M | −$19.26M |
| 2025 | $322.67M | −$60.51M | −$124.21M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Aug 2023)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.